Adding temporary disclaimer.

Adding temporary disclaimer.

Bug fixes

Bug fix

Bug fixes

New content from the Standards for Adult Immunization Practice has been incorporated into the Lipid Manager app.

This update includes underlying architecture improvements and minor reference link updates.

This app has been updated in accordance with the 2022 ACC ECDP on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of ASCVD Risk to incorporate newer nonstatin agents, such as bempedoic acid, evinacumab, and inclisiran. This update also includes improved risk discrimination in patient evaluation, now incorporating CAC scoring, evidence of subclinical atherosclerosis, and Familial Hypercholesterolemia.

The app name has changed from LDL-C Manager to Lipid Manager and added the new tool Hypertriglyceridemia.

Updated advice content and resources based on the 2018 ACC/AHA et al. Guideline on the Management of Blood Cholesterol

Updated content based on recent clinical trials, including FOURIER

• Incorporates Statin Intolerance as an in-app tool
• Typo fixes
• Bug fixes